NCT04820712View on ClinicalTrials.gov

Surgical Therapy and Survival in HCC/ C.F. Zhang et al.

CompletedOBSERVATIONAL

Enrollment

664

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions

Hepatocellular CarcinomaSurgery

Trial Locations (1)

510405

linzhu Zhai, Guangzhou

All Listed Sponsors

lead

Linzhu Zhai

OTHER

NCT04820712 - Surgical Therapy and Survival in HCC/ C.F. Zhang et al. | Biotech Hunter | Biotech Hunter